FairJourney Biologics
Ana Martins is a Senior Research Associate II at FairJourney Biologics since February 2023, bringing extensive experience from previous roles including Early Stage Researcher at Exiris s.r.l. and Visiting PhD Student at the University of Helsinki, both within the Marie Skłodowska-Curie European Training Network Magicbullet. At Exiris, Ana contributed to target identification and validation while developing antibody and drug conjugate technologies. Ana holds a PhD in Biochemistry from Bielefeld University, complemented by multiple master's degrees in Health Sciences and Applied Biology from Universidade do Minho and Università degli Studi di Milano, along with a Bachelor's degree in Biology and Geology.
This person is not in any offices
FairJourney Biologics
FairJourney Biologics is a privately established company with an outstanding track record of biotech and biopharmaceutical partners (Merus, argenX, BMS, Bayer, among others), offering a range of assets and services on antibody discovery, engineering, production, characterization up to cell line development stages. Our naïve and immune libraries from humans, rodents and llama, together with our know-how and internal technological development allow us to contribute to the pipeline of our partners on complex targets, leading to 14 known antibodies in the clinic. More recently, FairJourney Biologics has been joined by specialists in the field such as Tariq Ghayur (formerly Abbvie) and Rene Hoet (formerly Bayer), creating a panel of available scientists as service to support complex antibody projects. From target validation up to cell line development and pre-CMC reporting, FairJourney Biologics is a one stop shop leader in antibody services. As of 2022, the company has a headcount of above 200 staff members and a track record of more than 800 projects on a variety of areas.